Terpolymer Micelles for the Delivery of Arsenic to ... - ACS Publications

Oct 24, 2016 - Technologies (Grand Island, NY, USA). The MDA-MB-435 ...... (28) Gaspar, V. M.; Goncalves, C.; de Melo-Diogo, D.; Costa, E. C.;. Queiro...
2 downloads 0 Views 5MB Size
Subscriber access provided by CORNELL UNIVERSITY LIBRARY

Article

Terpolymer micelles for the delivery of arsenic to breast cancer cells: The effect of chain sequence on polymeric micellar characteristics and cancer cell uptake Qi Zhang, Mohammad Reza Vakili, Xing-Fang Li, Afsaneh Lavasanifar, and X. Chris Le Mol. Pharmaceutics, Just Accepted Manuscript • DOI: 10.1021/acs.molpharmaceut.6b00362 • Publication Date (Web): 24 Oct 2016 Downloaded from http://pubs.acs.org on October 26, 2016

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Molecular Pharmaceutics is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 40

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

Terpolymer micelles for the delivery of arsenic to breast cancer cells: The effect of chain sequence on polymeric micellar characteristics and cancer cell uptake

Qi Zhang a, Mohammad Reza Vakili b, Xing-Fang Li a, Afsaneh Lavasanifar b*, X. Chris Le a*

a

Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and

Pathology, Faculty of Medicine and Dentistry, University of Alberta b

Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta

Abstract: In this study, we developed a micellar platform composed of terpolymers for the encapsulation of inorganic arsenite or arsenous acid (AsIII). For this purpose, a series of terpolymers composed of poly(ethylene oxide) (PEO, block A), poly(α-carboxylate-εcarprolactone) (PCCL, block B), and poly(ε-caprolactone) (PCL, block C) with either a blocked, i.e., BC or CB, or random, i.e, (B/C)ran block copolymer sequence in the polyester segment were synthesized. The COOH groups on block B were further modified with mercaptohexylamine for AsIII encapsulation. We then investigated how block copolymer sequence of terpolymers can affect the stability and surface charge of micelles as well as the cellular uptake of their cargo, i.e., AsIII, by MDA-MB-435 cancer cells. 1H-NMR spectroscopy in D2O and CDCl3 was also used to study the structure of different terpolymer micelles. Our results showed micelles with ABC sequence to have better stability over ACB and A(B/C)ran ones as reflected by a lower critical micellar concentration (CMC). The AsIII-loaded ABC micelles were less negatively charged on the surface than the other two types of terpolymer micelles. In line with this observation, ABC 1 ACS Paragon Plus Environment

Molecular Pharmaceutics

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

micelles showed a substantially enhanced uptake of AsIII by MDA-MB-435 cancer cells. Stability and surface charge are key parameters that can influence the performance of polymeric micelles as nano-drug carriers. Based on these results, we suggest ABC micelles to have improved characteristics for AsIII delivery compared to ACB and A(B/C)ran micelles.

Key words: Polymeric micelles, terpolymer, drug delivery, arsenite, arsenic trioxide, cancer.

1. Introduction Polymeric micelles as nano-drug carriers have attracted great attention in recent decades.1-4 Several block copolymer micellar delivery systems developed in research labs are now under clinical testing for human use, mostly in the field of cancer therapy.5 The rapid advancement of polymeric micellar drug carriers from bench to bedside is owed to their proper characteristics for nano-drug delivery, such as small size, biocompatibility, pharmaceutical feasibility and high capacity for drug loading. Chemical flexibility of micellar building blocks is another advantage that has contributed to the success of polymeric micellar delivery systems significantly. The latter property is particularly important as it allows for engineering of the carrier for the accommodation of different drugs with versatile physicochemical characteristics as well as fine tuning of the micellar structure to fulfil specific delivery requirements. Amphiphilic block copolymers composed of poly(ethylene oxide) (PEO) and poly(εcaprolactone) (PCL) have been extensively studied and applied in drug delivery because PCL has good compatibility with a wide range of drugs. In addition, both PEO and PCL are FDAapproved biomaterials for medical application.6 Our research group has reported on the α-carbon functionalization of ε-caprolactone monomer with benzyl carboxylate, allowing post-

2 ACS Paragon Plus Environment

Page 2 of 40

Page 3 of 40

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

polymerization modification on the pendant groups of PCL block.7, 8 With functionalized PCL, polymeric micelles of improved stability, stimuli-responsive drug release and/or capacity for encapsulation of different therapeutics of varied chemical structure can be realized.7, 9 Previously, we developed a new strategy for efficient arsenic encapsulation in PEO-b-PCL based micelles with the ultimate aim to enhance the delivery of arsenic and extend the application of arsenic treatment to solid tumors, such as breast cancer.10 We modified the core-forming block of methoxy poly(ethylene oxide)-block-poly(α-carboxylic acid-ε-caprolactone) (PEO-b-PCCL) with a thiol-containing pendant group, i.e., mercaptohexylamine (NH2C6H12SH). With phenylarsine oxide (PAO), an organic arsenical that has high affinity for thiol groups, we demonstrated that the thiolated polymer can self-assemble into micelles which have high arsenic encapsulation capacity as well as triggered arsenic release property. Though carboxylic acid (COOH) groups in PEO-b-PCCL provide post-polymerization modification sites in the block copolymer structure, their presence on the polymer backbone was shown to decrease the thermodynamic stability of micelles perhaps because of a decrease in the hydrophobicity of the core-forming block.10-12 Micelle stability is an important factor in successful delivery of the cargo to solid tumor targets in vivo.13 In this study, in order to mitigate the negative impact of carboxylic acid groups on micellar stability, we introduced unmodified caprolactone segments to the poly(ester) part of micelle-forming block copolymers. We hypothesized that the introduction of an unmodified PCL with higher hydrophobicity compared to PCCL, can compensate for the negative impact of pendant COOH groups in the PCCL block on micellar stability and result in the design of efficient terpolymer micelles for targeted delivery of inorganic arsenite (AsIII) to solid tumors.

3 ACS Paragon Plus Environment

Molecular Pharmaceutics

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

In order to determine the micellar structures capable of targeted AsIII delivery, we investigated the influence of block sequence of PEO/PCCL/PCL terpolymers on micellar stability, surface charge and cellular AsIII uptake. Previous studies on the effect of block sequence and/or random versus block structure in triblock terpolymers on the characteristics of resulted micelles are limited.9,

14, 15

To this end, we prepared three terpolymers with varied

distribution of the unmodified caprolactone versus COOH modified caprolactone in the PCL/PCCL segment. This included a block sequence in the poly(ester) segment, i.e., PEO-bPCL-b-PCCL or PEO-b-PCCL-b-PCL block copolymers (shown as ACB and ABC polymers, respectively), and a random distribution, i.e., PEO-b-P(CL-co-CCL)ran (shown as A(B/C)ran polymers). We modified these three starting polymers with mercaptohexylamine and loaded AsIII into the terpolymeric micelles. The effect of block copolymer sequence on relevant micellar properties for AsIII delivery was then investigated.

2. Experimental section 2.1 Materials. All the chemicals and reagents, unless specified, were purchased from SigmaAldrich (St. Louis, MO, USA). Caprolactone (CL) was purchased from Alfa Aesar (Heysham, Lancashire, UK) and α-benzyl carboxylate-ε-caprolactone (BCL) from Alberta Research Chemicals Inc. (Edmonton, AB, Canada). Mercaptohexylamine hydrochloride was purchased from Annker Organics Co. Ltd. (Wuhan, Hubei, China). RPMI-1640 cell culture media, Dulbecco’s Phosphate-buffered saline without CaCl2 or MgCl2 (DPBS) and penicillin– streptomycin solution were purchased from Life Technologies (Grand Island, NY, USA). The MDA-MB-435 cancer cell line was originally received from the laboratory of Dr. R. Clarke, Georgetown University Medical School, Washington, DC, US. The cells were cultured in RPMI

4 ACS Paragon Plus Environment

Page 4 of 40

Page 5 of 40

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

1640 medium with 10% fetal bovine serum (FBS) and 1% penicillin–streptomycin solution at 37 °C and 5% CO2.

2.2 Terpolymer synthesis and thiol functionalization. The terpolymers with block sequence of ABC and ACB were synthesized through a two-step sequential ring opening polymerization reaction, and the polymer with A(B/C)ran sequence was synthesized in a one-step bulk ring opening polymerization (Scheme 1).12 Briefly, for the synthesis of PEO-b-PCCL-b-PCL (the ABC sequence) the macro-initiator methoxy PEO5000 (0.5 g, 0.1 mmol) was exposed to α-benzyl carboxylate-ε-caprolactone (BCL) (0.5 g, 2.0 mmol) and stannous octoate (40 mg, 0.1 mmol) under vacuum at 145°C for 4 to 6 h. The produced PEO-b-PBCL was then purified by solubilization in CH2Cl2 and precipitation in cold ethyl ether. The purified PEO-b-PBCL was dried under vacuum and analyzed by NMR to determine the degree of polymerization (DP) of BCL. PEO-b-PBCL was then used as the macro-initiator and reacted with caprolactone (CL) (0.14 g, 1.2 mmol) and stannous octoate (20 mg, 0.05 mmol) under vacuum at 145°C for 2 to 4 h, yielding the triblock PEO-b-PBCL-b-PCL. After purification with the same procedure to purify PEO-b-PBCL, PEO-b-PBCL-b-PCL was then analyzed by NMR to determine the DP of CL. The BCL units were then converted to α-carboxylic acid-ε-caprolactone (CCL) via hydrogen reduction catalyzed by 10% Pd on charcoal (20 wt% of the added polymer) in anhydrous THF. For the synthesis of PEO-b-PCL-b-PCCL (the ACB sequence), PEO5000 (0.5 g, 0.1 mmol) was first reacted with CL (0.5 g, 2.0 mmol) and then reacted with BCL (0.5 g, 2.0 mmol) in the presence of stannous octoate, and the produced PEO-b-PCL-b-PBCL underwent hydrogen reduction, following the same procedure for the synthesis of PEO-b-PCCL-b-PCL. For the synthesis of PEO-b-P(CL-co-CCL)ran (the random A(B/C)ran sequence), PEO5000 (0.5 g, 0.1 mmol) was reacted with a mixture of CL (0.14 g, 1.2 mmol) and BCL (0.5 g, 2.0 mmol) in the

5 ACS Paragon Plus Environment

Molecular Pharmaceutics

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

presence of stannous octoate (60 mg, 0.15 mmol). This was followed by the hydrogenation of the BCL units as explained before. The composition of polymer products was measured by 1H-NMR (Bruker Advance 600 MHz NMR spectrometer, Billerica, MA, USA) using CDCl3 as solvent. The DP of each block was calculated based on the 1H-NMR spectra of terpolymers, comparing the area under the peak for PEO5000 (4H, CH2-CH2-O, δ 3.5-3.8 ppm) to the methylene hydrogens of the benzyl group on the BCL units of PBCL (2H, C6H5-CH2-O-CO, δ 5.2 ppm), and to that of the α-methylene group on the CL units of PCL (2H, CO-CH2(CH2)3CH2-O, δ 2.2-2.4 ppm) or the ε-methylene groups on either CL, BCL, or CCL units on PCL, PBCL or PCCL, respectively (2H, COCH(R)(CH2)3CH2-O, δ 3.9-4.2 ppm). Detailed 1H-NMR spectrum information is described in Supporting Information. The molecular weight of terpolymers was further measured by gel permeation chromatography (GPC) (Supporting Information, Fig S2). In this manuscript, PEO-b-PCL-b-PCCL (ACB sequence) is denoted as polymer 1, PEO-b-P(CCL-co-CL)ran (A(B/C)ran sequence) as polymer 2, and PEO-b-PCCL-b-PCL (ABC sequence) as polymer 3 (Table 1). The conjugation of mercaptohexylamine to the polymer backbone was accomplished as reported before.10 Briefly, the COOH groups on a terpolymer were activated by oxalyl chloride (oxalyl chloride:COOH = 1.1:1, m/m) in chilled anhydrous CH2Cl2. The activation reaction ran for 24 h. The solvent was removed under vacuum and the chlorinated polymer was briefly washed with anhydrous hexane to remove un-reacted oxalyl chloride. The chlorinated polymer was then dissolved in anhydrous CH2Cl2 and reacted with SHC6H12NH2⋅HCl (SH:COOH = 1:1, m/m), which was pre-neutralized with anhydrous NEt3 (NEt3:SH = 2.2:1, m/m). The reaction was carried out in the dark for 20 h at room temperature. The solvent was again evaporated under

6 ACS Paragon Plus Environment

Page 6 of 40

Page 7 of 40

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

vacuum and the thiolated terpolymer product was dissolved in toluene. Salts such as NEt3⋅HCl could not be dissolved in toluene, which was removed by centrifugation. The thiolated terpolymers were then precipitated out in cold hexane. The polymers were further purified by dialysis against water to remove un-reacted mercaptohexylamine. 1H-NMR analysis confirmed the conjugation of thiol-containing pendant groups, as two peaks at δ 2.86 ppm (2H, CONHCH2-(CH2)4-CH2-SH) and δ 2.68 ppm (2H, CONHCH2-(CH2)4-CH2-SH) appeared. The thiolated terpolymers of the ACB, A(B/C)ran, and ABC block copolymer sequences are denoted as polymers 1a, 2a, and 3a, respectively (Scheme 1). 2.3 Encapsulation of AsIII. The encapsulation of AsIII by terpolymer micelles was accomplished using a previously published method for PAO encapsulation in thiolated PEO-bPCCL diblock copolymers with minor modification.10 Freshly synthesized thiolated polymers were dissolved in THF (10 mg/mL). The polymer solution (1 mL) was added drop-wise into NaAsO2 solution (4 mL) prepared in CH3COONH4 buffer (1.45 M, pH 7.4) supplemented with 10 mM tris(2-carboxyethyl)phosphine (TCEP) under vigorous stirring. Excessive amount of NaAsO2 was used for arsenic encapsulation (see Supporting Information). The mixture was incubated in a 37 °C water bath for 1 h. The THF was then evaporated during overnight stirring at room temperature. The un-loaded AsIII and the salts in the buffer were removed by dialysis against water for 24 h. The AsIII-loaded micelle solution was lyophilized for further characterization. The AsIII-loaded micelles made from the thiolated terpolymers with ACB, A(B/C)ran, and ABC sequences are denoted as 1b, 2b and 3b, respectively. The loading of arsenic was determined by inductively coupled plasma mass spectrometry (ICP-MS) (Agilent 7500cs Octopole Reaction System ICPMS, Santa Clara, CA, USA) as described in our previous paper.10 The loading of arsenic was expressed as weight percent of

7 ACS Paragon Plus Environment

Molecular Pharmaceutics

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

arsenic element in lyophilized AsIII-loaded polymeric micelle powder. The arsenic encapsulated polymers were subjected to elemental analysis (Carlo Erba EA 1108 elemental analyzer, Milan, Italy) to determine the sulfur content. The results were used to calculate the molar ratio of As to S in each polymer sample. 2.4 Characterization of micelles. The critical micellar concentration (CMC) of polymers 1, 2, 3 were measured using pyrene probe as reported previously.16 The zeta potential of micelles (1 mg/mL) prepared from polymers 1, 2, 3, 1a, 2a, 3a, 1b, 2b and 3b at different pH levels were measured using a Malvern Nano-ZS Zeta Sizer (Worcestershire, UK) (laser wavelength: 633 nm, temperature: 25 °C). The buffers for pH 4.5 and 5.0 were based on CH3COOK (0.1 M) and the buffers for pH 6.0, 7.0 and 10.5 were based on KH2PO4 (0.1 M). NaOH (1.0 M) solution was used to adjust the pH of buffers. Each micelle sample was vortexed, filtered through 0.45 µm PVDF filters and stabilized in a 4 °C fridge for 3 h before zeta potential measurement. The size distribution and Z-average diameter of AsIII-loaded micelles (0.1 mg/mL) in different solvents (water and PBS) were measured using Malvern Nano-ZS Zeta Sizer (Detecting light angle: 173°, temperature: 25 °C). The size and morphology of micelles were characterized by transmission electron microscope (TEM) (Supporting Information) and scanning transmission electron microscope (STEM). For STEM sample preparation, a 5 uL droplet of sample solution (2 mg/mL) was placed on glow discharged carbon film TEM grid. After settling for 30 seconds, excessive sample solution on the TEM grid was blotted with filter paper. The sample was then dried at ambient air. The STEM imaging was carried out on JEOL2200FS TEM/STEM at 200Kv in the mode of STEM high angle annular dark field (HAADF).17 2.5 1H-NMR of micelles in D2O. To evaluate the exposure of hydrophobic groups on the terpolymers to water, the micelle solutions (1 mg/mL) of polymers 1, 2, 3, 1a, 2a, and 3a were

8 ACS Paragon Plus Environment

Page 8 of 40

Page 9 of 40

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

prepared in D2O and CDCl3 for 1H-NMR analysis. In our study, the area under the peak of typical signals related to the hydrophobic groups (i.e., δ 2.4–2.2 ppm for CL, 2H per unit; δ 4.2– 3.9 ppm for both CL and CCL, 2H per unit; δ 2.96–2.78 ppm and δ 2.75–2.58 ppm for CCL-C6SH, 4H per unit) were measured and divided by the area under the peak of PEO5000 (δ 3.8–3.5 ppm, 4H per unit and 114 units in total). The ratios of areas under the peaks from the 1H-NMR spectra in D2O were compared to the corresponding ratios from 1H-NMR spectra of polymer samples in CDCl3. 2.6 In vitro arsenic release from micelles. The release of AsIII from three different micelles were evaluated in H2O, RPMI-1640 cell culture medium, and the cell culture medium supplemented with 10% FBS. We followed the method developed and shown in our previous paper.10 Briefly, 1 mg/mL micelle solution was prepared by direct reconstitution in H2O, RPMI1640 cell culture medium, or the RPMI-1640 medium supplemented with 10% FBS. The micelle solutions were incubated at 37 °C for 48 hs. At each time point (0, 1, 3, 6, 12, 24, 36, 48 h), 100 µL micelle solution aliquot was collected and centrifugally filtered using an Amicon Ultra-0.5 mL centrifugal filter (Molecular weight cutoff: 3,000 Da) at 13500 rpm for 40 min. The filtrate containing free AsIII was collected for arsenic quantification. Total arsenic concentration in the micelle sample and free AsIII concentration in the filtrate were determined by ICP-MS. The AsIII release was expressed as the weight percentage of free arsenic at each time point compared to the total arsenic in the sample. Free AsIII dissolved in water and the media was used as method control (see Supporting Information). 2.7 Cellular uptake of AsIII-loaded micelles. To study the cellular uptake of encapsulated AsIII by MDA-MB-435 cancer cells, we conducted two parallel sets of experiments at the same time. One set was to measure the arsenic concentration in homogenized cells, and the other was

9 ACS Paragon Plus Environment

Molecular Pharmaceutics

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 10 of 40

to measure the arsenic concentration in separated cell lysate and cell debris fractions. Both sets included three cell culture dishes for each arsenic formulation and a control treated with arsenicfree media. MDA-MB-435 cells (25 × 104 cells/mL, 2 mL) were seeded into each 60 × 15 mm cell culture dish. The cells were treated with 1b, 2b, 3b and free AsIII solutions within the 1/3 to 1/2 of their corresponding IC50 values. The IC50 values were determined using the neutral red assay as described in our previous publication (see Supporting Information).10 The exact arsenic concentration in the treatment medium was determined by ICP-MS. After 24 h treatment, the cells were washed with 3 mL Dulbecco’s PBS (DPBS) for three times. Double distilled water (ddH2O) (500 µL) was added into each culture dish. The cells were then scraped off from the dish and collected. The cells were lysed using freeze-thaw method. To determine the soluble protein concentration in lysed cell solution, the lysed cell solution was first centrifuged at 5000 rpm for 2 minutes, and 20 µL aliquot was collected from the supernatant for protein concentration determination following the standard Bradford assay protocol (the microplate edition). To determine the arsenic concentration in the homogenized cells, the lysed cell solution was acid-digested by 10% (v/v) HNO3 at 50 °C for 24 h. The digested cell solution was diluted and filtered, and analyzed by ICP-MS. To determine the arsenic concentration in cell lysate and cell debris, the lysed cell solution was first centrifuged at 5000 rpm for 2 minutes to separate cell debris and lysate (supernatant). The lysate was collected and the cell debris was re-suspended in 500 µL ddH2O. These two fractions of lysed cell samples underwent the same sample preparation procedures as the lysed cell solution and analyzed by ICP-MS analysis. The measured arsenic concentration was normalized to soluble protein concentration in lysed cell solution. The arsenic uptake was expressed as arsenic atoms per miligram of soluble protein in lysed cells. To mask the influence of arsenic treatment concentration variation on the cellular

10 ACS Paragon Plus Environment

Page 11 of 40

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

arsenic uptake amount, relative cellular arsenic uptake calculated by dividing the arsenic uptake value by the arsenic treatment concentration (µM) was reported. 2.8 Statistical Analysis. The results were expressed as mean±standard deviation (SD). Unpaired two-tailed Student’s t-test, One-way ANOVA with post-test of Tukey’s multiple comparison or Two-way ANOVA was selected to perform statistical analysis for each experiment in the results section. The software used was GraphPad Prism5 software (La Jolla, CA, USA). A value of P0.05, t-test) and similar arsenic concentrations in the homogenized cells (P>0.05, t-test).

4. Discussion Our long term objective is to design an optimum nanoparticle formulation for effective delivery of arsenic to solid tumors. Previously, we have developed thiolated polymeric micelles based on PEO-b-PCCL capable of PAO encapsulation through As–S bond formation. In this study, we tried to optimize this delivery system for the delivery of inorganic arsenite by mitigating the negative impact of carboxylic acid groups on the PCCL backbone on the stability of micelles. Towards this goal, unmodified caprolactone units were introduced to the polymer structure to increase the hydrophobicity of the poly(ester) segment. The effect of caprolactone unit placement in the developed terpolymer chains on the stability, drug release and cellular uptake of AsIII-loaded micelles was then evaluated. Three terpolymers composed of PEO (as the hydrophilic part), PCL and PCCL (as the hydrophobic part) with varying placement of CL units in the poly(ester) segment were synthesized (ABC, A(B/C)ran, and ACB terpolymers in Table 1). These terpolymers were further functionalized with mercaptohexylamine for AsIII encapsulation. Our assessments showed differences between characteristics of micelles formed from these three structures. In general, micelles formed from ABC polymer were particularly found to be superior in terms of micellar stability, arsenic release and cell uptake, although they have shown slightly lower arsenic loading compared to the other structures under study. Irrespective of the CL placement, the introduction of CL units was found to substantially decrease the CMC of polymers, indicating increased thermodynamic stability of micelles formed

22 ACS Paragon Plus Environment

Page 23 of 40

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

by CL-containing terpolymers. This finding is in coherence with reports of Yang et al24 who introduced ethyl carbonate (EC) units into p(ethylene glycol)-block-poly(acid carbonate) (PEGb-PAC) block copolymers and synthesized two blocked terpolymers of PEG-b-PEC-b-PAC and PEG-b-PAC-b-PEC, and one randomly distributed terpolymer PEG-b-PEAC. In that study, the addition of more hydrophobic EC units resulted in a decreased CMC values of terpolymers compared to PEG-b-PAC diblock polymer, regardless of the distribution of EC units in the terpolymers. The terpolymers with different chain arrangement showed different performance in terms of micellar thermodynamic stability. Polymers 1 and 2 had similar CMC values, both of which were larger than that of polymer 3. One may argue that the lower CMC of polymer 3 compared to polymer 1 might be due to lower CCL/CL unit number ratio in polymer 3. However, polymer 3 had similar CCL/CL unit number ratio as polymer 2, but still showed lower CMC. This observation suggest that polymer 3 with the ABC sequence are more stable than polymers with ACB and A(B/C)ran sequences. Yang et al evaluated the stability of micelles with different chain arrangement as well.24 In contrast to our observation, PEG-b-PEC-b-PAC micelles with the most hydrophobic block in the shell/core interface were more stable than PEG-b-PAC-b-PEC micelles. Micelles formed from polymer 3 series were also found to bear less negative charge on their surface compared to micelles from polymer 1 and 2 series. Consequently, micelles from polymer 3 provided higher uptake of incorporated arsenic in cancer cells compared to free arsenic and micelles from polymers 1 and 2. The cellular uptake of AsIII is via facilitated diffusion. Transporters involved in AsIII uptake include aquaglyceroporins25, such as AQP9 and AQP7, and glucose transporters26, such as GLUT1 and GLUT2. Therefore, the cellular uptake of AsIII is dependent on the expression of these transporters as well as the AsIII concentration gradient.

23 ACS Paragon Plus Environment

Molecular Pharmaceutics

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 24 of 40

After encapsulation of AsIII inside the micelles, the cellular uptake of the encapsulated AsIII is dependent on the properties of micelles.27 As observed in our study, the micelle encapsulation substantially enhanced the cellular uptake of AsIII compared to free AsIII. More importantly, micelle 3b with the least negative zeta potential had the highest cellular uptake of AsIII among the three types of micelles. This is attributed to the negative charge of phospholipids in the cell membrane that can repel nanoparticles of similar charge (e.g., micelles from polymers 1 and 2).21 We noticed that the arsenic content in the cell debris of cells treated with micelle 3b was substantially higher than those treated with micelles 1b and 2b (Figure 5). These results suggests micelle 3b to have better interaction with MDA-MB-435 cell membrane than micelles 1b and 2b, leading to high cellular uptake of arsenic. To explain our observations, we gained further insights into the structural differences between micelles from polymer 3 and those from polymers 1 and 2 using 1H-NMR spectroscopy in D2O versus CDCl3 (Table 3). Our NMR investigations implied the following: In ABC micelles, the PCL block locating at the hydrophobic end forms a compact micelle core, and the bulky PCCL or P(CCL/CCL-C6-SH) block forms the stealth layer; in A(B/C)ran micelles the core is occupied by bulky PCCL or P(CCL/CCL-C6-SH) block together with PCL block; and in ACB micelles, the core was formed by PCL block though PCL is the middle block of the terpolymer, and the bulky PCCL or P(CCL/CCL-C6-SH) block stretches out to the PEO corona layer (Scheme 2). A similar study on triblock amphiphilic polyelectrolyte micelles by Papagiannopoulos et al showed the volume fraction profiles of block terpolymeric micelles and revealed the micelle structures using SANS analysis.15 Papagiannopoulos et al demonstrated that (1) the core of ABC micelles (A: PEO, B: a charged poly[sodium(sulfamate/carboxylate)isoprene] (SCPI) block, C: a hydrophobic polystyrene (PS) block) was smaller than the core of ACB micelles; (2) ABC

24 ACS Paragon Plus Environment

Page 25 of 40

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

micelle structure had three layers, namely, the PS core, the SCPI stealth layer, and the PEO corona; (3) ACB micelle structure had three layers, namely, the PS core, the mixed SCPI/PEO on the PS/solution interface, and the SCPI corona (SCPI block was longer than PEO block); and (4) the polyelectrolyte SCPI segments can collapse onto the PS core, especially with ABC sequence. Our proposed micelle structures were in consistency with the micelle structure revealed by Papagiannopoulos et al. This hypothetical scheme (Scheme 2) is in line with other observations in this manuscript. For instance, the thiol group is more accessible in ACB micelles for arsenic interaction leading to better As/S ratios in ACB (1b) versus ABC (3b) micelles (Figure 1). Moreover, the compact core of the ABC micelles affords micelles which can resist perturbation by the solvent and electrolytes; whereas the ACB

micelles with the bulky PCCL or

P(CCL/CCL-C6-SH) block stretching out to the PEO layer are more vulnerable and accessible to the solvent (Figure S7). This might have led to better deprotonation of the COOH group and a higher negative zeta potential on the ACB micelle surface (Figure 3), leading to their lower cellular uptake. It should be noted that the reactivity of CL versus BCL monomers and statistical sequence of the random orientation of hydrophobic block was not known in this study, and this issue may also have a significant impact on the results observed for polymer 2 series. Our report confirms that the use of terpolymeric micelles to enable fine tuning of micelle characteristics and additional micelle functions compared to diblock copolymer micelles, although the effect of block sequence arrangement on micelle characteristics can vary in different terpolymer systems.14 Terpolymeric micelles may also prove to be advantageous to diblock copolymer micelles for multidrug co-encapsulation28, 29, stimuli responsive design30, 31, and multicompartment structure preparation32, 33, and there are increasing drug delivery studies using terpolymeric micelles. Considering the unpredictable effect of block sequence arrangement

25 ACS Paragon Plus Environment

Molecular Pharmaceutics

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 26 of 40

on micelle characteristics, more attention to the polymer chain design when triblock polymers are involved is warranted.

5. Conclusions and perspectives In this study, we focused on the evaluation of three block sequence isomers of PEO/PCL/PCCL terpolymers with regards to micelle stability, surface charge, arsenic loading, release, and cellular uptake. Our results show the block sequence to have great influence on the above characteristics. In particular, the results showed the ABC terpolymer 3b with PCL block at the terminal end to display maximum micelle stability, least negative surface, lowest arsenic burst release, and highest arsenic cellular uptake compared to other structures under study. Therefore, terpolymer micelles of ABC sequence are considered for further studies on AsIII delivery.

Acknowledgements The authors thank Dr. V. Somayaji, Mr. M-A Hoyle, Ms. J. Jones, and Ms. A. Oatway of the University of Alberta for NMR, FTIR, elemental analysis, and TEM, and Ms. H. Qian of National Institute of Nanotechnology for STEM analysis. The authors also thank Ms. Nasim Ghasemi for assistant in analysis of GPC results. This work was supported in part by the Canadian Institutes of Health Research, the Canada Research Chairs Program, the Natural Sciences and Engineering Research Council of Canada, and Alberta Health.

Supporting Information. Detailed NMR spectra, GPC condition, sample GPC chromatographs CMC determination, optimization of AsIII encapsulation procedures, size distribution of micelles measured by TEM and DLS, plots of micelle zeta potential vs pH, control experiment of arsenic

26 ACS Paragon Plus Environment

Page 27 of 40

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

release, as well as in vitro cytotoxicity evaluation of encapsulated AsIII were included in Supporting Information.

27 ACS Paragon Plus Environment

Molecular Pharmaceutics

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48

Page 28 of 40

Tables, schemes, and figures Table 1. Molecular weight, composition, molecular weight and critical micelle concentration (CMC) of terpolymers. Mol. Weight (g/mol) Denotation

Block copolymer sequence

1

ACB

2

A(B/C)ran

3

ABC

Polymer name and illustrationa

Compositionb

CMC ± SD (µg/mL)

NMR

MnGPC, MwGPC (PDIGPC)c

PEO114-b-PCL9-b-PCCL19

9028

9203,12907 (1.40)

36±3

PEO114-b-(PCL10-co-PCCL15)

8510

6387, 10757 (1.68)

36±2

PEO114-b-PCCL17-b-PCL11

8940

7761, 12798 (1.65)

11±1

Mn

PEO-b-PCL-b-PCCL

PEO-b-(PCL-co-PCCL)

PEO-b-PCCL-b-PCL

a. b. c.

: ethylene oxide (EO) unit; : carboxyl-caprolactone (CCL) unit; : caprolactone (CL) unit. The degree of polymerization of each block is represented as subscripts and was calculated based on 1H-NMR spectra for each polymer. The MnGPC, MwGPC and PDIGPC of starting polymers were measured by GPC.

28 ACS Paragon Plus Environment

Page 29 of 40

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48

Molecular Pharmaceutics

Table 2. Size of micelles formed from starting polymers and thiolated polymers, and AsIII-loaded micelles.

Block

Diameter (mean±SD, [N]) (nm) of

Z-average diameter ± SD (nm) and PdI in bracesa

copolymer

AsIII-loaded micellesb

Micelles from starting

Micelles from thiolated

AsIII-loaded

polymers

polymers

micelles

ACB

61±1 (0.41)

141±1 (0.21)

124±1 (0.23)

19±6 (111)

55±9 (50)

A(B/C)ran

72±1 (0.46)

130±1 (0.21)

121±4 (0.36)

27±6 (118)

Not measured

107±2 (0.20)

17±4 (73)

70±16 (26)

sequence

TEM with PTA staining

STEM-HAADF without PTA staining

317±7 (0.51) ABC

72±1 (0.54)

(Two peaks Peak 1:60-90 nm Peak 2: 450-650 nm )

a. b.

The Z-average diameter and PdI of micelles were measured by DLS. The diameterTEM of micelles in TEM images were measured using NanoMeasurer 1.2 software. More than 100 particles in one image were randomly selected for size measurement.

29 ACS Paragon Plus Environment

Molecular Pharmaceutics

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 30 of 40

Table 3. Ratio of CL, CCL, and CCL-C6-SH components in terpolymers calculated from 1HNMR spectra obtained in CDCl3 and D2O. Area under proton peaks of hydrophobic segments Ratio of the normalized area under proton peaks of normalized to that of PEO segment* hydrophobic segments in D2O to that in CDCl3 in CDCl3 in D2O CLD2O/CLCDCl3 CCLD2O/CCLCDCl3 CL CCL CL CCL 1 0.039 0.0833 0.036 0.039 0.9 0.47 2 0.0044 0.066 0.044 0.043 1 0.65 3 0.048 0.075 0.029 0.034 0.6 0.45 in CDCl3 in D2O CLD2O/CLCDCl3 CCL-C6-SHD2O/CCL-C6-SHCDCl3 CL CCL-C6-SH CL CCL-C6-SH 1a 0.050 0.068 0.028 0.085 0.56 1.26 2a 0.056 0.059 0.030 0.055 0.53 0.93 3a 0.057 0.053 0.029 0.043 0.50 0.82 * The peak area related to CL, CCL, and CCL-C6-SH components were calculated from the integral of peaks at δ 2.40 − 2.22 (2H, CL), δ 4.20 − 3.95 (2H, CL and CCL), δ 2.96 − 2.78 and δ 2.75 − 2.58 (4H, CCL-C6-SH), respectively. These proton peak areas were normalized against the proton peak area of PEO, which was calculated from the integral of peak δ 3.76 − 3.57 (114 × 4H, PEO).

30 ACS Paragon Plus Environment

Page 31 of 40

O

O

O H3C

O

,4

h

m

H

O H3C

O

m

O

O

140oC,

O

H3C

4h

O

O

m

C

O

O C6H5H2C

O

H3C

j

O

O CL, BCL

n

O

PEO-b-PCL

o

L

Sn(Oct)2,

n

,1 40

C

BCL

O

Sn (O ct )2

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

O

O

PEO-b-PCL-b-PBCL

j,k (random)

m

O

Sn(Oct)2, 140oC, 4 h Sn (O ct ) C 2,1 L, 4 BC 0 o L C, 4 h O H3C

O C6H5H2C O

O

O

PEO-b-(PCL-co-PBCL) O

m

O

O

CL

n

H3C

Sn(Oct)2, 140oC, 4 h

O O

O

O

m

O

O

C6H5H2C

C6H5H2C

PEO-b-PBCL

PEO-b-PBCL-b-PCL

O

O

O H3C

n

O

O O

O

m

n

j

O OH

Polymer 1: PEO-b-PCL-b-PCCL O H2 Pd/Charcol, 24 h

O

O H3C

Oxalyl chloride

O O

O

m

j,k (random)

dry CH2Cl2, 24 h

O OH

Polymer 2: PEO-b-(PCL-co-PCCL) O

O

O H3C

O O

O

m

n

j

O OH

Polymer 3: PEO-b-PCCL-b-PCL

O

O

O H3C

O O

O

m

n

j

O SH N H

Polymer 1a: PEO-b-PCL-b-P(CCLC6-SH) O Mercaptohexylamine, NEt3 dry CH2Cl2, 24 h

O

O H3C

O O

O

m

j,k (random)

O

SH N H

Polymer 2a: PEO-b-(PCL-co-P(CCLC6-SH)) O

O

O H3C

O O

O

m

n

j

O SH N H

Polymer 3a: PEO-b-P(CCLC6-SH)-b-PCL

Scheme 1. Synthesis of PEO/PCL/PCCL terpolymers and thiolated terpolymers.

31 ACS Paragon Plus Environment

j

Molecular Pharmaceutics

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 32 of 40

Scheme 2. Proposed structures of micelles assembled from starting polymers (polymers 1, 2, 3) and thiolated polymers (polymers 1a, 2a, 3a), and arsenic-loaded micelles (micelles 1b, 2b, 3b). 32 ACS Paragon Plus Environment

Page 33 of 40

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Molecular Pharmaceutics

Figure 1. Arsenic loading and As/S molar ratio in thiolated terpolymeric micelles encapsulated with AsIII. The data were expressed as mean ± SD (N = 3). One-way ANOVA with post-test of Tukey’s multiple comparison test was performed among three types of arsenic-encapsulated micelles. (*: P